PTC Therapeutics Announces Initiation of a Registration-Directed Clinical Trial to Evaluate Vatiquinone in Mitochondrial Epilepsy October 27, 2020
U.S. FDA Grants Fast Track Designation for ASP0367/MA-0211, a Selective PPARD Modulator being Developed for the Treatment of Primary Mitochondrial Myopathies October 26, 2020
Be Biopharma Launches with $52 Million Series A Financing to Advance B Cells as Medicines October 22, 2020
Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19 October 21, 2020
Recros Medica Adds Aesthetic Medical Device Executives Charlie Huiner and Mitch Levinson to Board of Directors October 21, 2020
